NEQSTENT

Serial Number 87266952
602

Registration Progress

Application Filed
Dec 13, 2016
Under Examination
Approved for Publication
Published for Opposition
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: NEQSTENT
Previous Owner: Cerus Endovascular Ltd.
Classes: 010

Trademark Image

NEQSTENT

Basic Information

Serial Number
87266952
Filing Date
December 13, 2016
Abandonment Date
June 6, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jul 24, 2018
Classes
010

Rights Holder

Cerus Endovascular Ltd.

99
Address
John Eccles House
Oxford Science Park
Oxford OX44GP
GB

Ownership History

Cerus Endovascular Ltd.

Original Applicant
99
Oxford GB

Legal Representation

Attorney
Peter Ludwig

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jul 24, 2018 MAB2 O ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND Loading...
Jul 24, 2018 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Dec 5, 2017 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
Dec 5, 2017 GNFR O FINAL REFUSAL E-MAILED Loading...
Dec 5, 2017 CNFR R FINAL REFUSAL WRITTEN Loading...
Sep 23, 2017 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 22, 2017 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 22, 2017 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 22, 2017 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2017 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 22, 2017 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 15, 2017 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 19, 2016 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 16, 2016 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 010
Adjunctive medical devices for endovascular occlusion and treatment of vascular abnormalities, namely, endovascular occluding devices that promote clot formation or thrombus in neurovascular and peripheral vascular structures; medical devices used in conjunction with other occluding devices for treatment of aneurysms and vascular disease
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
010